These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
114 related items for PubMed ID: 22768886
1. Association between sitagliptin adherence and self-monitoring of blood glucose. Nigam S, Virdi NS, Daskiran M, Kozma CM, Paris A, Dickson WM. J Diabetes Sci Technol; 2012 May 01; 6(3):555-62. PubMed ID: 22768886 [Abstract] [Full Text] [Related]
2. Hypoglycemia in patients with type 2 diabetes from India and Malaysia treated with sitagliptin or a sulfonylurea during Ramadan: a randomized, pragmatic study. Aravind SR, Ismail SB, Balamurugan R, Gupta JB, Wadhwa T, Loh SM, Suryawanshi S, Davies MJ, Girman CJ, Katzeff HL, Radican L, Engel SS, Wolthers T. Curr Med Res Opin; 2012 Aug 01; 28(8):1289-96. PubMed ID: 22738801 [Abstract] [Full Text] [Related]
8. Efficacy and safety of the dipeptidyl peptidase-4 inhibitor, sitagliptin, in patients with type 2 diabetes mellitus inadequately controlled on glimepiride alone or on glimepiride and metformin. Hermansen K, Kipnes M, Luo E, Fanurik D, Khatami H, Stein P, Sitagliptin Study 035 Group. Diabetes Obes Metab; 2007 Sep 01; 9(5):733-45. PubMed ID: 17593236 [Abstract] [Full Text] [Related]
9. Assessment of basal insulin adherence using 2 methodologies among Texas Medicaid enrollees with type 2 diabetes. Zhang H, Barner JC, Moczygemba LR, Rascati KL. J Manag Care Spec Pharm; 2020 Nov 01; 26(11):1434-1444. PubMed ID: 33119450 [Abstract] [Full Text] [Related]
10. Bioequivalence of sitagliptin/metformin fixed-dose combination tablets and concomitant administration of sitagliptin and metformin in healthy adult subjects: a randomized, open-label, crossover study. Migoya EM, Miller JL, Gutierrez M, Zheng W, Johnson-Levonas AO, Liu Q, Matthews CZ, Wagner JA, Gottesdiener KM. Clin Drug Investig; 2010 Nov 01; 30(12):855-66. PubMed ID: 20923244 [Abstract] [Full Text] [Related]
11. Frequency of self-monitoring of blood glucose in patients with type 2 diabetes: association with hypoglycaemic events. Farmer A, Balman E, Gadsby R, Moffatt J, Cradock S, McEwen L, Jameson K. Curr Med Res Opin; 2008 Nov 01; 24(11):3097-104. PubMed ID: 18828957 [Abstract] [Full Text] [Related]
13. Effect of sitagliptin on post-prandial glucagon and GLP-1 levels in patients with type 1 diabetes: investigator-initiated, double-blind, randomized, placebo-controlled trial. Garg SK, Moser EG, Bode BW, Klaff LJ, Hiatt WR, Beatson C, Snell-Bergeon JK. Endocr Pract; 2013 Nov 01; 19(1):19-28. PubMed ID: 23186950 [Abstract] [Full Text] [Related]
14. Baseline characteristic differences between patients prescribed sitagliptin vs. other oral antihyperglycemic agents: analysis of a US electronic medical record database. Zhang Q, Rajagopalan S, Mavros P, Engel SS, Davies MJ, Yin D, Radican L. Curr Med Res Opin; 2010 Jul 01; 26(7):1697-703. PubMed ID: 20465367 [Abstract] [Full Text] [Related]
18. Sitagliptin in clinical practice: a new approach in the treatment of type 2 diabetes. Florentin M, Liberopoulos EN, Mikhailidis DP, Elisaf MS. Expert Opin Pharmacother; 2008 Jul 01; 9(10):1705-20. PubMed ID: 18570604 [Abstract] [Full Text] [Related]